Liver regeneration following experimental major hepatectomy with choledochojejunostomy

British Journal of Surgery

Volumn 102, Issue 11, 2015, Pages 1410-1417

  Takagi, T ^a   Yokoyama, Y ^a   Kokuryo, T ^a   Yamaguchi, J ^a   Nagino, M ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL; BILE DUCT BYPASS; CHOLANGITIS; EVALUATION STUDY; LIVER; LIVER REGENERATION; LIVER RESECTION; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; RAT; SURGERY; WISTAR RAT;

ANIMALS; BIOMARKERS; CHOLANGITIS; CHOLEDOCHOSTOMY; HEPATECTOMY; LIVER; LIVER REGENERATION; MALE; POSTOPERATIVE COMPLICATIONS; RATS; RATS, WISTAR;

EID: 84941190663     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9908     Document Type: Article

References (19)

1. Yokoyama Y, Ebata T, Igami T, Sugawara G, Ando M, Nagino M,. Predictive power of prothrombin time and serum total bilirubin for postoperative mortality after major hepatectomy with extrahepatic bile duct resection. Surgery 2014; 155: 504-511.
2. Sugawara G, Ebata T, Yokoyama Y, Igami T, Takahashi Y, Takara D, et al. The effect of preoperative biliary drainage on infectious complications after hepatobiliary resection with cholangiojejunostomy. Surgery 2013; 153: 200-210.
3. Panis Y, Fagniez PL, Brisset D, Lacaine F, Levard H, Hay JM,. Long term results of choledochoduodenostomy versus choledochojejunostomy for choledocholithiasis. The French Association for Surgical Research. Surg Gynecol Obstet 1993; 177: 33-37.
4. Yokoyama Y, Ebata T, Igami T, Sugawara G, Mizuno T, Nagino M,. The adverse effects of preoperative cholangitis on the outcome of portal vein embolization and subsequent major hepatectomies. Surgery 2014; 156: 1190-1196.
5. Watanabe K, Yokoyama Y, Kokuryo T, Kawai K, Kitagawa T, Seki T, et al. Segmental cholangitis impairs hepatic regeneration capacity after partial hepatectomy in rats. HPB (Oxford) 2010; 12: 664-673.
6. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, et al,. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274: 1379-1383.
7. Clavien PA,. IL-6, a key cytokine in liver regeneration. Hepatology 1997; 25: 1294-1296.
8. Yamada Y, Kirillova I, Peschon JJ, Fausto N,. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 1997; 94: 1441-1446.
9. Feingold KR, Soued M, Grunfeld C,. Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats. Biochem Biophys Res Commun 1988; 153: 576-582.
10. Michalopoulos GK, Zarnegav R,. Hepatocyte growth factor. Hepatology 1992; 15: 149-155.
11. Selzner M, Clavien PA,. Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology 2000; 31: 35-42.
12. Yu H, Wu SD,. Activation of TLR-4 and liver injury via NF-kappa B in rat with acute cholangitis. Hepatobiliary Pancreat Dis Int 2008; 7: 185-191.
13. Pirisi M, Scott CA, Fabris C, Cavarape A, Federico E, Falleti E, et al. Endotoxin priming and liver damage by experimental duodenal obstruction in the rat. Pathol Int 2000; 50: 34-40.
14. Weiss YG, Bellin L, Kim PK, Andrejko KM, Haaxma CA, Raj N, et al. Compensatory hepatic regeneration after mild, but not fulminant, intraperitoneal sepsis in rats. Am J Physiol Gastrointest Liver Physiol 2001; 280: G968-G973.
15. Seehofer D, Stockmann M, Schirmeier A, Nüssler AK, Cho SY, Rayes N, et al. Intraabdominal bacterial infections significantly alter regeneration and function of the liver in a rat model of major hepatectomy. Langenbecks Arch Surg 2007; 392: 273-284.
16. Enayati P, Brennan MF, Fong Y,. Systemic and liver cytokine activation. Implications for liver regeneration and posthepatectomy endotoxemia and sepsis. Arch Surg 1994; 129: 1159-1164.
17. Quiroz SC, Bucio L, Souza V, Hernández E, González E, Gõmez-Quiroz L, et al. Effect of endotoxin pretreatment on hepatic stellate cell response to ethanol and acetaldehyde. J Gastroenterol Hepatol 2001; 16: 1267-1273.
18. Schirmacher P, Geerts A, Pietrangelo A, Dienes HP, Rogler CE,. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology 1992; 15: 5-11.
19. Corpechot C, Barbu V, Wendum D, Chignard N, Housset C, Poupon R, et al. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis. Am J Pathol 2002; 160: 613-620.